JPRN-jRCT2071230038RecruitingPhase 1
A Phase I Clinical Study of NS-863 in Healthy Subjects
Higashioka Masaya0 sites158 target enrollmentStarted: July 8, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 158
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to < 65age old (—)
- Sex
- All
Inclusion Criteria
- •1) Provided written informed consent
- •2) Japanese male subjects
- •3) White male subjects
- •4) Japanese female subjects of non-childbearing potential
Exclusion Criteria
- •1) Subjects with a history of surgery which may have an impact on drug absorption
- •2) Subjects with a history of allergy or hypersensitivity to drugs or foods
- •3) Subjects who collected 200 mL or more of whole blood or component blood within 2 weeks before administration of the study drug
- •4) Subjects who have received other investigational products within 16 weeks (112 days) prior to the first investigational product administration
Investigators
Similar Trials
Recruiting
Phase 1
A Phase I Clinical Study of NS-025 in Healthy SubjectsJPRN-jRCT2031220474Higashioka Masaya122
Completed
Phase 1
Clinical Pharmacology Study of NS-580 in Healthy female subjects (Phase I Study)endometriosisJPRN-jRCT2071220011Higashioka Masaya64
Completed
Phase 1
Clinical Pharmacology Study of NS-229 in Healthy male subjects (Phase I Study) (Drug-Drug Interaction Study with Prednisolone)JPRN-jRCT2051210094Higashioka Masaya20
Recruiting
Phase 1
A Phase I Clinical Study of NS-161 in Healthy Female SubjectsHealthy volunteerJPRN-jRCT2071220066Higashioka Masaya130
Unknown
Phase 1
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16